Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,965,583 papers from all fields of science
Search
Sign In
Create Free Account
raxibacumab
Known as:
raxibacumab monoclonal antibody, human
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Monoclonal Antibodies
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Monoclonal antibodies against infectious microbes: so long and too little!
G. M. Raj
,
Rekha Priyadarshini
,
S. Murugesan
,
M. Adhimoolam
Infectious Diseases - Drug Targets
2020
Corpus ID: 212690732
Monoclonal antibodies (mAbs) as alternatives or more often as complementary to the conventional antimicrobials are being…
Expand
2015
2015
Simulated Implications of Predicted PA Kinetics in Humans for Treatment of Inhalational Anthrax A. Corey* Parexel International Objectives: Extrapolated protective antigen (PA) kinetics in humans…
2015
Corpus ID: 115143705
Methods: Human raxibacumab concentration-time profiles were simulated using an existing model for healthy subjects [1]. Since…
Expand
2013
2013
Animal rule for drug approval creates a jungle of confusion
E. Dolgin
Nature Network Boston
2013
Corpus ID: 205376261
In 2002, in the aftermath of the 9/11 attacks, the US introduced the ‘animal rule’ as a way for the country’s regulators to…
Expand
2013
2013
UCSD researcher shot by cofounder
L. Laursen
Nature Biotechnology
2013
Corpus ID: 8734312
volume 31 NumBeR 11 NovemBeR 2013 nature biotechnology virus. Synagis was developed by MedImmune of Gaithersburg, Maryland, now a…
Expand
2013
2013
Raxibacumab: Monoclonal antibody for inhalational anthrax
Maria G. Tanzi
2013
Corpus ID: 75962280
2010
2010
Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?
S. Antoniu
Expert Opinion on Investigational Drugs
2010
Corpus ID: 577029
Importance of the field: Inhalational anthrax is a disease with a high lethality potential and current therapeutic interventions…
Expand
Review
2009
Review
2009
FDA Pipeline preview, December 2009 (Denosumab, Binodenoson, Toremifene 80 mg, Zolpidem tartrate sublingual tablet, QAB149, Raxibacumab, Rituximab, Pneumococcal 13-valent conjugate vaccine…
F. Staff
2009
Corpus ID: 70443728
Recent FDA action (through Dec 2009) related to denosumab, binodenoson, toremifene 80 mg, zolpidem tartrate sublingual tablet…
Expand
2008
2008
Safety and Pharmacokinetics of Raxibacumab: A Novel Agent for the Treatment of Inhalational Anthrax
Letha M. Healey
2008
Corpus ID: 147019251
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE